These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 28138159)
1. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease. Chu J; Lauretti E; Praticò D Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159 [TBL] [Abstract][Full Text] [Related]
2. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway. Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909 [TBL] [Abstract][Full Text] [Related]
4. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
5. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. Dobarro M; Gerenu G; Ramírez MJ Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694 [TBL] [Abstract][Full Text] [Related]
7. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737 [TBL] [Abstract][Full Text] [Related]
8. Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease. Sen T; Saha P; Jiang T; Sen N Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4418-4427. PubMed ID: 32051249 [TBL] [Abstract][Full Text] [Related]
9. Curcumin attenuates amyloid-β-induced tau hyperphosphorylation in human neuroblastoma SH-SY5Y cells involving PTEN/Akt/GSK-3β signaling pathway. Huang HC; Tang D; Xu K; Jiang ZF J Recept Signal Transduct Res; 2014 Feb; 34(1):26-37. PubMed ID: 24188406 [TBL] [Abstract][Full Text] [Related]
10. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX; Zhao RP; Wang DS; Wang AN Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [TBL] [Abstract][Full Text] [Related]
11. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease. He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160 [TBL] [Abstract][Full Text] [Related]
12. Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. Reifert J; Hartung-Cranston D; Feinstein SC J Biol Chem; 2011 Jun; 286(23):20797-811. PubMed ID: 21482827 [TBL] [Abstract][Full Text] [Related]
13. Qingxin Kaiqiao Fang decreases Tau hyperphosphorylation in Alzheimer's disease via the PI3K/Akt/GSK3β pathway in vitro and in vivo. Liu S; Xu L; Shen Y; Wang L; Lai X; Hu H J Ethnopharmacol; 2024 Jan; 318(Pt B):117031. PubMed ID: 37579924 [TBL] [Abstract][Full Text] [Related]
14. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105 [TBL] [Abstract][Full Text] [Related]
15. GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease. Zhao J; Li X; Chen X; Cai Y; Wang Y; Sun W; Mai H; Yang J; Fan W; Tang P; Ou M; Zhang Y; Huang X; Zhao B; Cui L J Cell Physiol; 2019 Jul; 234(7):10411-10420. PubMed ID: 30511419 [TBL] [Abstract][Full Text] [Related]
16. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C; Xu B; Sun X; Zhu Q; Sui Y Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757 [TBL] [Abstract][Full Text] [Related]
17. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Ali T; Kim MO J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697 [TBL] [Abstract][Full Text] [Related]
18. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models. Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697 [TBL] [Abstract][Full Text] [Related]
20. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]